Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
11.39
-0.04 (-0.35%)
At close: Jun 26, 2026, 4:00 PM EDT
11.56
+0.17 (1.49%)
Pre-market: Jun 29, 2026, 5:05 AM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $994.89 million as of June 29, 2026. Its market cap has increased by 256.39% in one year.
Market Cap
994.89M
Enterprise Value
493.50M
1-Year Change
256.39%
Ranking
Category
Stock Price
$11.39
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $994.89M, a decrease of -44.56%. That is a compound annual growth rate of -9.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 994.89M | -49.41% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 1.03B |
| ORIC Pharmaceuticals | 986.52M |
| Alpha Tau Medical | 981.12M |
| DBV Technologies | 969.96M |
| Kura Oncology | 967.64M |
| Replimune Group | 960.32M |
| Avalo Therapeutics | 956.69M |
| Alto Neuroscience | 948.94M |